Session Recap: How AI Powers Precision Engagement: Key Takeaways from Preeti Ravaliya & Ramya Maddilate at Future Pharma

Future Pharma 2026

June 1 - 2, 2026

Renaissance Seaport District, Boston, MA

Session Recap: How AI Powers Precision Engagement: Key Takeaways from Preeti Ravaliya & Ramya Maddilate at Future Pharma

06/26/2025

At Future Pharma’s session "From Data to Decisions: How AI is Powering the Next Era of Precision Engagement," leaders from Day One BioPharmaceuticals, Preeti Ravaliya, Director of Commercial Analytics, and Ramya Maddilate, Director of HCP & KOL Marketing, shared how their team leverages AI and strategic data analytics to tackle market challenges in pediatric oncology. The conversation centered on actionable steps and industry-first best practices for scaling commercial impact with limited resources—a crucial topic for pharma and biotech leaders seeking transformative engagement strategies.

Key Takeaways

1. Data and Marketing Form a Power Partnership

Investing in robust data infrastructure is non-negotiable for personalized, omni-channel engagement in pharma. Gathering physician-level data from diverse sources, such as claims, internal analytics, and engagement, enables targeted, scalable outreach, aligning marketing and strategic business objectives.

2. AI Drives Precision at Scale

Leveraging AI and machine learning lets small teams optimize outreach and resource allocation, especially in complex markets with limited budgets and high stakes. Day One’s physician prioritization model identifies “best-fit” prescribers and predicts prescription behaviors, redirecting marketing efforts for maximum return.

3. Omnichannel Triggers Accelerate Adoption

A focus on omnichannel, trigger-based campaigns helped Day One exceed revenue goals and speed adoption. Targeted messages are delivered across digital and personal channels, based on real-time behavior and affinity data. For example, tailoring communications for digitally engaged physicians. This approach ensures the brand remains top of mind when key treatment decisions are made.

4. Content Strategy Matters More Than Ever

Strategic investment in peer-led, AI-developed content drives meaningful engagement and prescription results. Collaborating closely with medical/legal/regulatory teams (MLR) streamlines content creation, even on limited budgets, ensuring rapid, compliant development of educational material.

5. Iterative Learning Unlocks Commercial Success

Adopting a crawl-walk-run approach, starting with pilots, refining use cases, and scaling best practices, enabled rapid adjustment and buy-in from sales and marketing. Continuous optimization and close alignment between teams were cited as core contributors to sustained market success.

In Their Words

“Data and marketing is a power partnership, you can’t do effective omni-channel personalized content without the right data. So investing in that up front is critical, and the infrastructure’s really non-negotiable.”
Preeti Ravaliya, Director, Commercial Analytics, Day One BioPharmaceuticals

Why It Matters

As pharma and biotech navigate fragmented markets, smaller patient populations, and rising expectations for personalized experiences, integrating AI-driven analytics and strong cross-team collaboration is becoming vital. Leaders who redesign processes to prioritize efficiency, digital engagement, and scalable personalization transform every decision into lasting commercial advantage. Day One BioPharmaceuticals’ journey shows that achieving meaningful engagement and rapid adoption is possible, regardless of company size, when innovation, agility, and data-driven insights guide strategy.

Actionable Insights

  • Build a robust data infrastructure: Ensure access to physician-level data as a foundation for engagement.
  • Prioritize AI-powered segmentation: Invest in machine learning models to target prescribers and allocate resources efficiently.
  • Activate omnichannel triggers: Reach physicians where and how they want to be engaged, using real-time behavioral data.
  • Invest in rapid, compliant content: Collaborate closely with MLR for agile, educational content development.

Explore What’s Next in Pharma

Eager for more future-facing strategies from Future Pharma? Learn more about the event or catch up on other keynotes for actionable ideas every pharma marketer needs.